Riggs Rory B 的 Form 4 申報
Royalty Pharma plc（RPRX），2021/12/30 申報
- 申報編號
- 0001209191-21-071640
- 申報時間
- 2021/12/30
- 交易日
- 2021/12/28-12/29
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 9 筆非衍生性交易。公開市場賣出合計 $740.1 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Riggs Rory BCIK 0001016835 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/12/28 | Class A Ordinary Shares | J其他取得 | +3,212 | –F2 | – | 625,610 | 直接 | |
| 2021/12/28 | Class A Ordinary Shares | J其他取得 | +42,138 | –F2 | – | 667,748 | 直接 | |
| 2021/12/28 | Class A Ordinary Shares | J其他處分 | −150,997 | –F4 | – | 349,552 | 間接 | |
| 2021/12/28 | Class A Ordinary Shares | J其他處分 | −707,155 | –F5 | – | 1,142,415 | 間接 | |
| 2021/12/28 | Class A Ordinary Shares | J其他處分 | −407,400 | –F6 | – | 708,245 | 間接 | |
| 2021/12/28 | Class A Ordinary Shares | S賣出處分 | −47,578 | $40.21F7 | −$1,913,111.38 | 301,974 | 間接 | |
| 2021/12/28 | Class A Ordinary Shares | S賣出處分 | −26,677 | $40.21F7 | −$1,072,682.17 | 1,115,738 | 間接 | |
| 2021/12/28 | Class A Ordinary Shares | S賣出處分 | −35,193 | $40.21F8 | −$1,415,110.53 | 673,052 | 間接 | |
| 2021/12/29 | Class A Ordinary Shares | S賣出處分 | −75,000 | $40.00F9 | −$3,000,000 | 592,748 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Pro rata distribution from a limited liability company of which the Reporting Person is a member.
表 I 有 2 筆交易的價格引用這則附註。
- F4
New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.
表 I 有 1 筆交易的價格引用這則附註。
- F5
New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.
表 I 有 1 筆交易的價格引用這則附註。
- F6
New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.05 to $40.57 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
表 I 有 2 筆交易的價格引用這則附註。
- F8
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $40.57 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F9
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.85 to $40.29 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。